ASX:AT1Health Care Equipment & ServicesHealth Care Equipment

ATOMO DIAGNOSTICS ORD

$0.023
$0.001 (4.17%)
Day Range
$0.023 - $0.024
52 Week Range
$0.014 - $0.048
Volume
656.40K
Avg Volume (10D)
2.07M
Market Cap
$20.72M
Price Chart
Market Statistics
Open$0.023
Previous Close$0.024
Day High$0.024
Day Low$0.023
52 Week High$0.048
52 Week Low$0.014
Valuation
Market Cap20.72M
Shares Outstanding901.08M
Price to Book2.93
Trading Activity
Volume656.40K
Value Traded15.12K
Bid$0.022 × 635,044
Ask$0.023 × 198,590
Performance
1 Day0.00%
5 Day-11.11%
13 Week-41.46%
52 Week26.32%
YTD-33.33%
Technical Indicators
RSI (14)25.71
50-Day SMA$0.033
200-Day SMA$0.029
Latest News
Atomo Diagnostics to supply HIV test kits across SA and Victoria as part of national vending machine program
Biotechnology

Atomo Diagnostics to supply HIV test kits across SA and Victoria as part of national vending machine program

Atomo Diagnostics (ASX: AT1) has received a $230,000 order from Thorne Harbour Health for HIV Self Test kits to support a national scale-up of the federal government’s CONNECT program, which provides free kits through vending machines. Thorne’s order will supply kits to machines across South Australia and Victoria as part of the government’s pilot program […]

2 min read
Imelda Cotton
Imelda Cotton
Weekly wrap: WiseTech relief rally helps market to bounce higher
Hot Topics

Weekly wrap: WiseTech relief rally helps market to bounce higher

After days of fairly salacious headlines around WiseTech founder Richard White and his penchant for delivering mansions to girlfriends, the company pushed the entire Australian market into making a small gain. News that Mr White would step aside as chief executive but will return in a full-time product and business development consulting role led to […]

6 min read
John Beveridge
John Beveridge
Atomo Diagnostics secures $2.44m grant to develop first rapid active syphilis self-test
Biotechnology

Atomo Diagnostics secures $2.44m grant to develop first rapid active syphilis self-test

Atomo Diagnostics (ASX: AT1) has again been recognised by the Australian government with the award of a $2.44 million grant to develop a unique syphilis test. The Australian-based medical device company was awarded the CRC-P industry grant from the Department of Industry, Science and Resources (DISR) to support the development of an innovative rapid active […]

2 min read
Colin Hay
Colin Hay
Atomo Diagnostics boosted by federal funding for HIV prevention and self-test expansion
Biotechnology

Atomo Diagnostics boosted by federal funding for HIV prevention and self-test expansion

Medical device company Atomo Diagnostics (ASX: AT1) has welcomed the Australian government’s commitment to fund the expansion of self-testing procedures for human immunodeficiency virus (HIV) in this week’s federal budget. The company anticipates that a significant portion of the $43.9 million committed to HIV prevention will be used for the procurement of more of its […]

1 min read
Imelda Cotton
Imelda Cotton